In situ characterization of nanoparticle biomolecular interactions in complex biological media by flow cytometry

Nature Communications

Volumn 7, Issue , 2016, Pages

  Lo Giudice, Maria Cristina ^a   Herda, Luciana M ^a   Polo, Ester ^a   Dawson, Kenneth A ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HUMAN SERUM ALBUMIN; NANOPARTICLE; POLYSTYRENE; PROTEIN CORONA; QUANTUM DOT; TRANSFERRIN; ANTIBODY; PROTEIN; PROTEIN BINDING; SERUM ALBUMIN;

BIOLOGICAL ANALYSIS; BIOMARKER; EXPERIMENTAL STUDY; FLOW CYTOMETRY; MOLECULAR ANALYSIS; NANOPARTICLE;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; DISPERSION; EPITOPE MAPPING; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; IN VIVO STUDY; MICROFLUIDIC ANALYSIS; MOLECULAR INTERACTION; NORMAL HUMAN; ALGORITHM; CHEMISTRY; IMMUNOLOGY; METABOLISM; PROCEDURES; SPECTROFLUOROMETRY;

ALGORITHMS; ANTIBODIES; FLOW CYTOMETRY; HUMANS; NANOPARTICLES; PROTEIN BINDING; PROTEINS; QUANTUM DOTS; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE; TRANSFERRIN;

EID: 84995426837     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms13475     Document Type: Article

References (52)

1. Cedervall, T. et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl Acad. Sci. USA 104, 2050-2055 (2007).
2. Monopoli, M. P., Aberg, C., Salvati, A. & Dawson, K. A. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 7, 779-786 (2012).
3. Tenzer, S. et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol. 8, 772-781 (2013).
4. Rocker, C., Potzl, M., Zhang, F., Parak, W. J. & Nienhaus, G. U. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nat. Nanotechnol. 4, 577-580 (2009).
5. Schöttler, S. et al. Protein adsorption is required for stealth effect of poly(ethylene glycol)-and poly(phosphoester)-coated nanocarriers. Nat. Nanotechnol. 11, 372-377 (2016).
6. Deng, Z. J., Liang, M., Monteiro, M., Toth, I. & Minchin, R. F. Nanoparticleinduced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat. Nanotechnol. 6, 39-44 (2011).
7. Xue, X. et al. Aggregated single-walled carbon nanotubes attenuate the behavioural and neurochemical effects of methamphetamine in mice. Nat. Nanotechnol. 11, 613-620 (2016).
8. Dobrovolskaia, M. A. & McNeil, S. E. Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2, 469-478 (2007).
9. He, X. et al. Quantifying the biodistribution of nanoparticles. Nat. Nanotechnol. 6, 755-755 (2011).
10. Shaw, C. A. et al. Protein corona formation in bronchoalveolar fluid enhances diesel exhaust nanoparticle uptake and pro-inflammatory responses in macrophages. Nanotoxicology 10, 981-991 (2016).
11. Kreyling, W. G. et al. In vitro and in vivo interactions of selected nanoparticles with rodent serum proteins and their consequences in biokinetics. Beilstein J. Nanotechnol. 5, 1699-1711 (2014).
12. Hu, W. et al. Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano 5, 3693-3700 (2011).
13. Cifuentes-Rius, A., de Puig, H., Kah, J. C. Y., Borros, S. & Hamad-Schifferli, K. Optimizing the properties of the protein corona surrounding nanoparticles for tuning payload release. ACS Nano 7, 10066-10074 (2013).
14. Ferrari, M. Nanogeometry: beyond drug delivery. Nat. Nanotechnol. 3, 131-132 (2008).
15. Huang, R., Carney, R. P., Ikuma, K., Stellacci, F. & Lau, B. L. T. Effects of surface compositional and structural heterogeneity on nanoparticle-protein interactions: different protein configurations. ACS Nano 8, 5402-5412 (2014).
16. Walkey, C. D. et al. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano 8, 2439-2455 (2014).
17. Treuel, L. et al. Impact of protein modification on the protein corona on nanoparticles and nanoparticle-cell interactions. ACS Nano 8, 503-513 (2014).
18. Hadjidemetriou, M. et al. In vivo biomolecule corona around blood-circulating, clinically used and antibody-targeted lipid bilayer nanoscale vesicles. ACS Nano 9, 8142-8156 (2015).
19. Sakulkhu, U. et al. Ex situ evaluation of the composition of protein corona of intravenously injected superparamagnetic nanoparticles in rats. Nanoscale 6, 11439 (2014).
20. Di Silvio, D. et al. Technical tip: high-resolution isolation of nanoparticle-protein corona complexes from physiological fluids. Nanoscale 7, 11980-11990 (2015).
21. Del Pino, P. et al. Protein corona formation around nanoparticles-from the past to the future. Mater. Horiz. 1, 301-313 (2014).
22. Jaiswal, J. K., Goldman, E. R., Mattoussi, H. & Simon, S. M. Use of quantum dots for live cell imaging. Nat. Methods 1, 73-78 (2004).
23. Medintz, I. L. et al. A fluorescence resonance energy transfer-derived structure of a quantum dot-protein bioconjugate nanoassembly. Proc. Natl Acad. Sci. USA 101, 9612-9617 (2004).
24. Medintz, I. L., Uyeda, H. T., Goldman, E. R. & Mattoussi, H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mater. 4, 435-446 (2005).
25. Chattopadhyay, P. K., Perfetto, S. P., Yu, J. & Roederer, M. The use of quantum dot nanocrystals in multicolor flow cytometry. WIREs Nanomed. Nanobiotechnol. 2, 334-348 (2010).
26. Resch-Genger, U., Grabolle, M., Cavaliere-Jaricot, S., Nitschke, R. & Nann, T. Quantum dots versus organic dyes as fluorescent labels. Nat. Methods 5, 763-775 (2008).
27. Van der Vlist, E. J., Nolte-'t Hoen, E. N. M., Stoorvogel, W., Arkesteijn, G. J. A. & Wauben, M. H. M. Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by high-resolution flow cytometry. Nat. Protoc. 7, 1311-1326 (2012).
28. Jaye, D. L., Bray, R. A., Gebel, H. M., Harris, W. A. C. & Waller, E. K. Translational applications of flow cytometry in clinical practice. J. Immunol. 188, 4715-4719 (2012).
29. Van Der Pol, E., Van Gemert, M. J. C., Sturk, A., Nieuwland, R. & Van Leeuwen, T. G. Single versus swarm detection of microparticles and exosomes by flow cytometry. J. Thromb. Haemost. 10, 919-930 (2012).
30. Freyssinet, J. M. & Toti, F. Membrane microparticle determination: At least seeing what's being sized! J. Thromb. Haemost. 8, 311-314 (2010).
31. Kelly, P. M. et al. Mapping protein binding sites on the biomolecular corona of nanoparticles. Nat. Nanotechnol. 10, 472-479 (2015).
32. Perfetto, S. P., Chattopadhyay, P. K. & Roederer, M. Seventeen-colour flow cytometry: unravelling the immune system. Nat. Rev. Immunol. 4, 648-655 (2004).
33. Moyano, D. F., Liu, Y., Peer, D. & Rotello, V. M. Modulation of immune response using engineered nanoparticle surfaces. Small 12, 76-82 (2016).
34. Hedde, P. N. et al. Stimulated emission depletion-based raster image correlation spectroscopy reveals biomolecular dynamics in live cells. Nat. Commun. 4, 2093 (2013).
35. Albanese, A. et al. Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles. ACS Nano 8, 5515-5526 (2014).
36. Ritz, S. et al. Protein corona of nanoparticles: distinct proteins regulate the cellular uptake. Biomacromolecules 16, 1311-1321 (2015).
37. Raesch, S. S. et al. Proteomic and lipidomic analysis of nanoparticle corona upon contact with lung surfactant reveals differences in protein, but not lipid composition. ACS Nano 9, 11872-11885 (2015).
38. Klein, J. Probing the interactions of proteins and nanoparticles. Proc. Natl. Acad. Sci. USA 104, 2029-2030 (2007).
39. Bisker, G. et al. Protein-targeted corona phase molecular recognition. Nat. Commun. 7, 10241 (2016).
40. Casals, E., Pfaller, T., Duschl, A., Oostingh, G. J. & Puntes, V. Time evolution of the nanoparticle protein corona. ACS Nano 4, 3623-3632 (2010).
41. Hajipour, M. J., Laurent, S., Aghaie, A., Rezaee, F. & Mahmoudi, M. Personalized protein coronas: A 'key' factor at the nanobiointerface. Biomat. Sci. 2, 1210-1221 (2014).
42. Dobrovolskaia, M. A. et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine 5, 106-117 (2009).
43. Barrán-Berdón, A. L. et al. Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery. Langmuir 29, 6485-6494 (2013).
44. Milani, S., Baldelli Bombelli, F., Pitek, A. S., Dawson, K. A. & Rädler, J. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. ACS Nano 6, 2532-2541 (2012).
45. Wei, Q. et al. Protein interactions with polymer coatings and biomaterials. Angew. Chem. Int. Ed. Engl. 53, 8004-8031 (2014).
46. Salvati, A. et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol. 8, 137-143 (2013).
47. Hristov, D. et al. Tuning of nanoparticle biological functionality through controlled surface chemistry and characterisation at the bioconjugated nanoparticle surface. Sci. Rep. 5, 17040 (2015).
48. Rai, A. J. et al. HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples. Proteomics 5, 3262-3277 (2005).
49. Hlady, V. & Buijs, J. Protein adsorption on solid surfaces. Curr. Opin. Biotech. 7, 72-77 (1996).
50. Gallo, J., Garca, I., Genicio, N. & Penadés, S. CdTe-based QDs: preparation, cytotoxicity, and tumor cell death by targeting transferrin receptor. Part. Part. Syst. Char. 31, 126-133 (2014).
51. Beaumont, P. C., Johnson, D. G. & Parsons, B. J. J. Chem. Soc. Faraday Trans. 89, 4185-4191 (1993).
52. Magde, D., Rojas, G. E. & Seybold, P. G. Solvent dependence of the fluorescence lifetimes of xanthene dyes. Photochem. Photobiol. 70, 737-744 (1999)